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Abstract
Generally animal and human cells use oxygen during their whole life. Consequently the oxygen use
is a simple indicator to test the vitality of cells. When the vitality decreases by the delivery of toxic
substances the decrease can be observed directly by the oxygen-use of the cells. To get fast
information of the vitality of cells we have measured the O2-tension by testing a new model of a
bioreactor, the Cell Vitality Checker 96 (CVC96), in practical application. With this CVC96, soon
a simple test will exist for the measurement of the oxygen use. In this respect the question had to
be answered whether the use in the laboratory is easy and whether oxygen as a parameter in the
vitality test can also be applied in future for problems in the field of material testing.
Background
A recent challenge to bone and cartilage tissue engineering
is to lift up research-scale products to a level of reproduc-
ible tissue substitute fabrication that is clinically effective,
e.g. by the use of bioreactors [1,2]. Bioreactors can be con-
sidered as devices in which biological and/or biochemical
processes are performed under controlled conditions (e.g.
pH, temperature, pressure, oxygen supply, nutrient supply
and waste removal). Most of the bioreactors were initially
developed to test biomaterials [3]. The survival of cells in
vivo as well as in bioreactors depends on the response of
the distinct cells to the environment. A higher oxygen ten-
sion for example is needed for osteoblastic differentiation,
whereas prolonged hypoxia favours formation of cartilage
or fibrous tissue [4]. The adjustment of oxygen tension in
bioreactors is therefore a critical aspect in bioreactor
design. The simplest and most widely used bioreactor for
bone and cartilage tissue engineering today is indeed the
culture dish [5]. Animal and human cells use oxygen dur-
ing their whole life. Consequently the oxygen use is a sim-
ple indicator to test the vitality of cells.
Vitality and cytotoxicity tests are established techniques in
different fields such as cell culture control, search of active
agents and also in other medical techniques. To the broad
field of medical technology belongs also the testing of
biocompatibility in the field of development and exami-
nation of tooth- and bone replacement tissues in cranio-
maxilliofacial surgery. The research group for biomineral-
ization and tissue engineering of this department carries
out the testing of biocompatibility.
Methods
Up to now the temporal course of cell reactions on toxic
influences could be observed only with a high input of
labor time (and costs). Because of this high input we have
tested the new measuring technology CVC96 with a short
test in practical applications. CVC96 allows the possibility
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field of vitality tests was the reason for a fundamental
application test in our research unit. CVC96 is a lid for 96-
well cell culture plates, which is used instead of the stand-
ard lid. CVC96 has a pin for each well, which is placed in
the middle of a well (Fig. 1a,b).  This means, the pins are
dipped in the cell culture medium. The pin is in the
medium without any contact to the cells at the bottom of
the well. The top of each pin is covered by a gas permeable
membrane. Within this membrane a fluorescent dye is
embedded, which shows its fluorescence in dependence
of the O2-tension. Thus CVC96 shows O2-dependent sig-
nals without contact to cells or irritation of cells. In this
case a simple conventional fluorescence-reader for micro
titer plates is sufficient for read out after incubation. Dur-
ing complete measurements there is no contact of pin or
fluorescent dye to the cells and no chemicals have to be
added, thus saving the procedure of pipetting. Since the
cells are not influenced by the measurement, the measure-
ments can be repeated at anytime and thus a kinetic pro-
file can be registered. This is not possible with standard
vitality tests, which are end-point assays. Thus it is possi-
ble to get more relevant data than up to now, since also
the speed of cellular responses can be determined directly.
Further, a definite evaluation of a test experiment is often
possible many hours earlier, because the "end point" of
an assay doesn't need to be awaited. The new test can be
controlled during its course and stopped as soon as a clear
result is received. Since the cells are not consumed or
affected during the test, further analyses with the same
cells are possible if needed. For instance after a test exper-
iment also used cell media can be taken in order to deter-
mine, after corresponding analysis, rates of uptake of
sublethal toxic material, because the cells remain intact
and contain absorbed substances. A microscopical control
of the cells after the assay is also possible. The effect on the
vitality of the cells inclusively can be received visually and
correlated in a single assay. The practical test was carried
Front (a) and back (b) side of the CVC96-lidigure 1
Front (a) and back (b) side of the CVC96-lid.
Table 1: DSMZ Cell Culture Data for L-929 cells.
Cell line: L-929
Cell type: mouse connective tissue fibroblast
Origin: established from the normal subcutaneous areola and adipose tissue of a male C3H/An mouse; used as target in TNF detection 
assays
Morphology: fibroblasts growing as monolayer
Medium: 90% RPMI 1640 + 10% FBS
Subculture: split confluent cultures 1:5 to 1:10 using trypsin (do not use trypsin/EDTA); after 2–3 days monolayer will be confluent; split 2–
3 times a week; seed out initially at about 1.0–2.0 × 106 cells/25 cm2
Incubation: at 37°C with 5% CO2
Doubling time: ca. 21–24 hours
Harvest: ca. 4–8 × 106 cells/25 cm2
Storage: frozen with 70% medium, 20% FBS, 10% DMSO at about 1–2 × 106 cells/ampoule
Mycoplasma: negative in DAPI, microbiological culture, PCR assays
Species: confirmed as mouse with IEF of AST, MDH, PEP B
Cytogenetics: murine hypertriploid karyotype – 61–67, 12–16 centric fusion markers present
Viruses: ELISA: reverse transcriptase negativePage 2 of 4
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chemia Diagnostics from an early product series. The
analysis of a general usefulness in a laboratory was a fun-
damental point of interest. It was the goal to find out
whether usage and measurement would be easy. A further
question was whether the quality and plausibility of the
received data would be convincing. Finally the question in
our research unit should be answered, whether our
research project could use this assay in future. The experi-
ments were carried out in L-929 cell cultures (Tab.1) [6-9].
The L-929 cell cultures were seeded in 96-wells. After
becoming confluent, the cells were treated with three dif-
ferent types of media: a) media that had been incubated
for 10 days with PMMA (poly-methyl-methacrylate), a
preferable inert material for applications in medical tech-
nology, b) media that had been incubated for ten days
with a collagen matrix, a material known to support the
growth of bone cells. Besides the differently treated cells
also untreated cells were measured as a reference. Further
glutaraldehyde, a toxic chemical substance, was added to
the L-929 cell cultures in different concentrations (0.1%,
1.0%, 10%). The cells were kept at 37°C in CO2-incuba-
tors during the whole experimental time and were
removed from the incubator only for measurements. The
measurements were carried out in a fluorescence-reader,
FLX800T instrument from Bio-Tek Instruments GmbH,
with which the data could be read in discontinuous
kinetic files. The same modified media with PMMA and
collagen were also tested for cell vitality in an identical
attempt with following evaluation by a Resazurin-assay
(CCS-PRINCESS® CELIA Instant Cytotoxicity-Assay 2004).
Results and discussion
Living human and animal cells need and use oxygen, so
that the culture medium with living cells contains rela-
tively less oxygen than the surrounding atmosphere. Con-
tinuously oxygen diffuses into the cell culture medium.
Glutaraldehyde induces the dying of cells and therefore
the consumption of oxygen by living cells decreases and
the share of oxygen in the cell medium increases (Fig. 2,
top). Not only clear results evolve, which reflect the row
of different concentrations of the toxic substance glutaral-
dehyde, but furthermore this kinetic registration is the
basis for further future information. A clear correct result
of those assays would result already in 5–10 hours. So
working time to get first useable results can be saved in
this kinetic experiment. Besides the principle suitability of
the tests for the clarification of cytotoxic effects it is also
very important for clinical applications to know the appli-
cability of this covers to test clinical materials, here PMMA
and collagen matrix (Fig. 2, bottom). These two sub-
stances were incubated with cell medium whereby the
influence of the two substances on cells is sufficiently
known, and both are used in dental medical research and
application. The manipulated media were sterilized again,
respectively and used as the cell media in the following
Resazurin-Assay for a comparison of vitality of L-929-cells incubated with medium, odifed by PMMA and by collagen matrix for 20 h (n = 8) (PRINCESS® CELI Assay of CCS,H mb g)Figure 3
Resazurin-Assay for a comparison of vitality of L-929-cells 
incubated with medium, modifed by PMMA and by collagen 
matrix for 20 h (n = 8) (PRINCESS® CELIA Assay of CCS, 
Hamburg).
Measuring curves of the kinetic course of the oxygen-signals [measured ∆ fluorescence in normaliz d relative fluores-cence u its (nrfu)] from L-929-cells ncubated with m dia, (top) which had been treated with d fferen  cyto oxic glut r-ald hyde oncent ati s (0.1%,1%,10%) a d (bot m) modi-fi d med a by PMMA a d by collagen mat ix for 20 h, r s ct velyFigur  2
Measuring curves of the kinetic course of the oxygen-signals 
[measured ∆ fluorescence in normalized relative fluores-
cence units (nrfu)] from L-929-cells incubated with media, 
(top) which had been treated with different cytotoxic glutar-
aldehyde concentrations (0.1%,1%,10%) and (bottom) modi-
fied media by PMMA and by collagen matrix for 20 h, 
respectively.Page 3 of 4
(page number not for citation purposes)
Head & Face Medicine 2006, 2:6 http://www.head-face-med.com/content/2/1/6Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
CVC96 experiments. The measurement of cell oxygen
consumption is a sufficient tool for characterization of
cell promotion or an impaired cell activity by biomaterials
in vitro.
The differences between the influence of collagen matrix,
which showed as to expected a clear stimulating effect on
the cells and that of PMMA, which showed no differences
to the untreated medium, is clearly visible (Fig. 2, bot-
tom). Also for this question clear results can be observed
after 5 to 10 hours.
Comparing measurements by a Resazurin assay show
identical tendencies (Fig. 3). For this first practical test of
CVC96, the Resazurin assay has been done only with n =
8, because effects of PMMA and collagen are well known
[10-13]. While the demoted PMMA-medium shows iden-
tical vitality to the untreated medium a clear stimulation
can be observed with collagen matrix. Since the Resaz-
urin-assay shows a consuming "end-point"-determina-
tion only one measuring point after 20 h for incubation is
registered.
The usage of the new CVC96-assays is easier in relation to
the standard assays, because the pipetting work steps are
not necessary. The quality of the data and their reliability
increase by kinetic evaluation. The experiments can be
carried out in shorter time, because in many cases no
standardized temporal end-point of the measurement has
to be awaited.
Conclusion
Up to now only the results of first praxis tests could be
shown. Surpassing this first practical test in future, the
validity of the data in relation to standard tests must be
intensively investigated so that afterwards fundamental
questions of biocompatibility can be investigated for pure
and mixed materials. We regard CVC96 as an interesting
assay which allows new possibilities of investigations on
the basis of kinetic observations and gives new insights
and faster results. Thus it should be extensively validated
after being brought onto the market by the producer. This
will include statistical relevant testing with different kind
of cells and a greater number n of tested material.
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